- Dodik nije političar, kako smatra Kukić, koji je dosljedan, pa ga ne bi čudilo da se Dodik distancira od svojih stavova.Šmit ima priliku da raspetlja gordijski čvor u jednom potezu - smatra Kukić.
"Ovai susret sa kancelarkom Merkel je važan, ona tim želi da pokaže interesovanje za dešavanja u BiH i time želi da pokaže interesovanje za ono što Incko ima da kaže i želi da pruži punu podršku Šmitu, to je nedvosmislena poruka", rekao je Vučić.
china? i ask then president trump about it back in may of 2020. so a terrible thing happened and you can look at it as a source. it took place in a certain at a certain point and it could have been put out. and it should have been put out. and we asked to go over and they said no. they didn t want our help. and i told you, that was okay, because they must know what they re doing. it was either stupidity, incompetence or it was deliberate. one or the other. maria: former secretary of state mike pompeo on thiso morning about his probe of the origins of covid-19 and why joe biden s foreign policy seems to be helping china, iran and russia instead of america. plus, president biden s mega spending plans, the $6 trillion budget nobody seems to be talking about. house budget committee ranking r member jason commit smit on how
Strategic Funding to advance Drug Candidate
Jan 14 2021 Read 170 Times
Biologics manufacturer eleva GmbH has secured up to EUR 60 million in funding from Zukunftsfonds Heilbronn (ZFHN). The funds will help advance one of its drug candidates, CPV-101, to stages that will facilitate further investment from venture capitalists and/or pharmaceutical companies. The company also announced the addition of Dr. Ralf Smit to its Executive Board.
The Freiburg-based company developed its moss-based platform to produce biologics like antibodies, replacement enzymes, or fusion toxins. The funding from ZFHN, an investor in local start-ups, will is now providing help take CPV-101, a potentially game-changing complement regulator, to more advanced clinical stages and further investments This will enable additional investment on the path to approval.